Table 2.
Non-stimulated PB-ECFCs | VT-stimulated PB-ECFCs | |||
---|---|---|---|---|
Pathway name | Statistics | Pathway name | Statistics | |
Metabolic pathways | p = 3.25e−08 | Metabolic pathways | p = 9.94e−05 | |
Cell cycle | p = 1.78e−05 | Cell cycle | p = 0.0027 | |
Glycolysis / Gluconeogenesis | p = 1.78e−05 | Glycolysis / Gluconeogenesis | p = 0.0088 | |
Renal cell carcinoma | p = 0.0003 | Renal cell carcinoma | p = 2.92e−06 | |
Glycine, serine and threonine metabolism | p = 0.0003 | Glycine, serine and threonine metabolism | p = 0.0030 | |
TGF-beta signaling pathway | p = 0.0003 | TGF-beta signaling pathway | p = 0.0112 | |
p53 signaling pathway | p = 0.0031 | p53 signaling pathway | p = 0.0088 | |
Purine metabolism | p = 0.0037 | Purine metabolism | p = 0.0052 | |
Pentose phosphate pathway | p = 0.0068 | |||
Mucin type O-Glycan biosynthesis | p = 0.0077 | |||
Cysteine and methionine metabolism | p = 0.0093 | |||
Fructose and mannose metabolism | p = 0.0093 | |||
Cytokine-cytokine receptor interaction | p = 0.0140 | Cytokine-cytokine receptor interaction | p = 4.74e−05 | |
mTOR signaling pathway | p = 0.0167 | |||
Adipocytokine signaling pathway | p = 0.0247 | Adipocytokine signaling pathway | p = 0.0088 | |
Pathways in cancer | p = 0.0247 | Pathways in cancer | p = 0.0007 | |
ECM-receptor interaction | p = 0.0338 | |||
Ribosome | p = 0.0371 | Ribosome | p = 0.0064 | |
PPAR signaling pathway | p = 4.74e−05 | |||
Axon guidance | p = 0.0219 | |||
Focal adhesion | p = 0.0450 |
The KEGG pathways involved in angiogenesis and metabolism with a p < 0.05 are show. Red is upregulated and green is downregulated.